麦草畏市场前景持续看好。截至2015年10月31日,在我国登记麦草畏原药产品(总含量从80%~98%)并在有效期内的的企业达到27家,其中国外企业1家,国内企业26家。 Dicamba market prospects continue to be optimistic. As of 31 October 2015, there were 27 enterprises that registered the dicamba drug products in China (total content from 80% to 98%) and were in the period of validity, including 1 foreign enterprise and 26 domestic enterprises.